On July 18, 2018, after months of alluding to the various aspects of an upcoming “Biosimilar Action Plan” as another prong within FDA’s broader Drug Competition Action Plan (DCAP), FDA finally ...

While the Biden administration and US Congress continue to debate ways to address perceived prescription drug pricing concerns, the Food and Drug Administration (FDA) is taking action. Under its Drug ...

The US FDA Commissioner Scott Gottlieb announced new steps aimed at speeding up the process of reviewing generic drug marketing application and boosting competition. In a statement, the FDA regulator ...

SILVER SPRING, Md., May 11, 2018 /PRNewswire-USNewswire/ -- Today is an important day in the Administration's collaborative effort to address the rising cost of drugs. We know that the high list cost ...

FALLS CHURCH, Va., Nov. 25, 2019 /PRNewswire-PRWeb/ -- The Future of Generic Drug Competition Deconstructing FDA and Congressional Initiatives **An FDAnews Webinar ...

The Food and Drug Administration's Office of Generic Drugs had a good 2019. The agency's director, Sally Choe, noted in recent comments that the office worked diligently to ensure that the generic ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...